Alamar Biosciences, Inc. Common Stock ALMR
Analyst Ratings
- Consensus
- Buy — 4 Buy · 0 Hold · 0 Sell (4 analysts)
- Avg. Price Target
- $33.00 (+2.7% upside)
Key Stats
- Today's Range
- $32.06 – $33.68
- 50-Day Range
- $23.32 – $38.54
- 52-Week Range
- $18.84 – $38.54
- Volume
- 353K shs
- Average Volume
- 397K shs
- Market Cap
- $2.31 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.66%
- Days to Cover
- 1.48
About Alamar Biosciences, Inc. Common Stock
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Related Stocks
Compare head-to-head: ALMR vs WAT·ALMR vs RVTY·ALMR vs TXG·ALMR vs BIO
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.